Literature DB >> 4044337

Radiotherapy alone in breast cancer. I. Analysis of tumor parameters, tumor dose and local control: the experience of the Gustave-Roussy Institute and the Princess Margaret Hospital.

R Arriagada, H Mouriesse, D Sarrazin, R M Clark, G Deboer.   

Abstract

This retrospective study involved 463 breast cancer patients treated by radiotherapy alone at the Princess Margaret Hospital and at the Institut Gustave-Roussy. These patients either had operable tumors, but were unfit for general anesthesia, or had inoperable tumors due to local contraindications to surgery. Results were analyzed according to tumor response, local recurrence rate, tumor size, tumor fixation, nodal fixation and tumor dose. Conventional statistical analysis of local control showed two significant factors: tumor dose and tumor size. Multivariate analysis permitted to define an "individual risk" (IR) of local recurrence according to three independent factors: tumor size, tumor fixation, and nodal fixation. It was shown that the IR was a good prognostic factor for local control. Increase in tumor dose gave a similar effect in the local recurrence relative risk for all the IR groups. According to the slope of the dose-effect curve, it was deduced that a dose increase of 15 Gy can decrease the relative risk of local recurrence 2-fold. In fact, it was shown that tumor dose was the most significant independent factor on local control, able to produce up to a 10-fold increase compared to 2-fold decrease for tumor size. If the IR of local recurrence is known, a theoretical predictive value on local control, taking into account the tumor dose, can be determined according to the present data.

Entities:  

Mesh:

Year:  1985        PMID: 4044337     DOI: 10.1016/0360-3016(85)90027-6

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  14 in total

Review 1.  Medical and radiation oncology for breast cancer in developing countries with particular reference to locally advanced breast cancer.

Authors:  Elizabeth M Murray
Journal:  World J Surg       Date:  2003-06-06       Impact factor: 3.352

2.  Prognostic factors and natural history in lymph node-negative breast cancer patients.

Authors:  R Arriagada; L E Rutqvist; L Skoog; H Johansson; A Kramar
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

3.  Definitive single fraction stereotactic ablative radiotherapy for inoperable early-stage breast cancer: A case report.

Authors:  Manasa Veluvolu; Mausam Patel; Ganesh Narayanasamy; Thomas Kim
Journal:  Rep Pract Oncol Radiother       Date:  2020-07-11

4.  Modeling the effect of tumor size in early breast cancer.

Authors:  Claire Verschraegen; Vincent Vinh-Hung; Gábor Cserni; Richard Gordon; Melanie E Royce; Georges Vlastos; Patricia Tai; Guy Storme
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

5.  Hyperthermia improves local tumour control in locally advanced breast cancer.

Authors:  G Wiedemann; O Mella; R S Coltart; B C Schem; O Dahl
Journal:  Klin Wochenschr       Date:  1988-10-17

Review 6.  Clinical practice guidelines for the care and treatment of breast cancer: 15. Treatment for women with stage III or locally advanced breast cancer.

Authors:  Tamara Shenkier; Lorna Weir; Mark Levine; Ivo Olivotto; Timothy Whelan; Leonard Reyno
Journal:  CMAJ       Date:  2004-03-16       Impact factor: 8.262

7.  The management of locally advanced breast cancer.

Authors:  R D Rubens
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

8.  Breast dose heterogeneity in CT-based radiotherapy treatment planning.

Authors:  R Prabhakar; G K Rath; P K Julka; T Ganesh; R C Joshi; N Manoharan
Journal:  J Med Phys       Date:  2008-04

9.  Evaluation of overall survival and barriers to surgery for patients with breast cancer treated without surgery: a National Cancer Database analysis.

Authors:  D Boyce-Fappiano; I Bedrosian; Y Shen; H Lin; O Gjyshi; A Yoder; S F Shaitelman; W A Woodward
Journal:  NPJ Breast Cancer       Date:  2021-07-05

Review 10.  Establishing the Role of Stereotactic Ablative Body Radiotherapy in Early-Stage Breast Cancer.

Authors:  Aisling Barry; Anthony Fyles
Journal:  Int J Breast Cancer       Date:  2018-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.